Ep154: Robert Ang on CRISPR to Protect Bone Marrow & Attack Cancer episode artwork

EPISODE · Feb 9, 2024 · 1H 3M

Ep154: Robert Ang on CRISPR to Protect Bone Marrow & Attack Cancer

from The Long Run with Luke Timmerman · host Timmerman Report

Robert Ang, CEO of Cambridge, Mass.-based Vor Bio, on using CRISPR gene editing to alter bone marrow transplants and improve treatment of acute myeloid leukemia.

Robert Ang, CEO of Cambridge, Mass.-based Vor Bio, on using CRISPR gene editing to alter bone marrow transplants and improve treatment of acute myeloid leukemia.

NOW PLAYING

Ep154: Robert Ang on CRISPR to Protect Bone Marrow & Attack Cancer

0:00 1:03:14

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of The Long Run with Luke Timmerman?

This episode is 1 hour and 3 minutes long.

When was this The Long Run with Luke Timmerman episode published?

This episode was published on February 9, 2024.

What is this episode about?

Robert Ang, CEO of Cambridge, Mass.-based Vor Bio, on using CRISPR gene editing to alter bone marrow transplants and improve treatment of acute myeloid leukemia.

Can I download this The Long Run with Luke Timmerman episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!